Pacific Biosciences Of California (PACB) Net Equity Issued and Repurchased (2010 - 2026)
Pacific Biosciences Of California's Net Equity Issued and Repurchased was $255,000 in Q2 2026, down 82.3% from the prior quarter.
Powered by 
Analysis
Pacific Biosciences Of California (PACB) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pacific Biosciences Of California's Net Equity Issued and Repurchased was $3.16 million through Jun 30, 2026, up 14.1% year-over-year; for FY2025, it was $3.43 million, down 55.5% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -40.6% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $7.7 million in FY2024 (-95.9%), $189.2 million in FY2023, $11.23 million in FY2022 (-64.7%) and $31.81 million in FY2021 (-31.4%).
- The Q2 2026 figure marks the lowest quarterly Net Equity Issued and Repurchased since Q1 2020.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q3 2025 (growth of 80.9%); the worst was Q1 2024 (a decline of 96.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | - |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 3.00 Mn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | - |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 65.60 Mn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 20.00 Mn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | - |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 5.00 Mn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 53.80 Mn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | - |
| 10 | Pacific Biosciences Of California | 736.62 Mn | -354.38 Mn | 12.64 Mn | 255,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 255,000.00 |
| Mar 31, 2026 | 1.44 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Sep 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 6.89 Mn |
| Mar 31, 2023 | 189.20 Mn |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | 3.54 Mn |
| Jun 30, 2022 | 848,000.00 |
| Mar 31, 2022 | 5.59 Mn |
| Dec 31, 2021 | 1.69 Mn |
| Sep 30, 2021 | 4.81 Mn |
| Jun 30, 2021 | 2.97 Mn |
| Mar 31, 2021 | 22.34 Mn |
| Dec 31, 2020 | 32.19 Mn |
| Sep 30, 2020 | 13.35 Mn |
| Jun 30, 2020 | 628,000.00 |
| Mar 31, 2020 | 199,000.00 |
| Dec 31, 2019 | 131,000.00 |
API Access
Pacific Biosciences Of California Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PACB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PACB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PACB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();